Page last updated: 2024-08-22

cladribine and Leukemia P388

cladribine has been researched along with Leukemia P388 in 7 studies

*Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. [MeSH]

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (71.43)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clayton, SD; Montgomery, JA; Riordan, JM; Secrist, JA; Shortnacy-Fowler, AT1
Ciesielska, E; Robak, T; Szmigielska-Kaplon, A; Szmigiero, L1
Góra-Tybor, J; Robak, T2
Auer, B; Föger, B; Geisen, F; Hoppichler, F; Konwalinka, G; Lechleitner, M; Patsch, JR; Schirmer, M; Zilian, U1
Marañda, E; Robak, T; Szmigielska, A1
Robak, T; Szmigielska, A1

Other Studies

7 other study(ies) available for cladribine and Leukemia P388

ArticleYear
Synthesis and biologic activity of 2'-fluoro-2-halo derivatives of 9-beta-D-arabinofuranosyladenine.
    Journal of medicinal chemistry, 1992, Jan-24, Volume: 35, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Escherichia coli; HIV; Humans; Leukemia P388; Mice; Purine-Nucleoside Phosphorylase; Structure-Activity Relationship; Tumor Cells, Cultured; Vidarabine

1992
Anthracyclines potentiate activity against murine leukemias L1210 and P388 in vivo and in vitro.
    European journal of haematology, 2002, Volume: 68, Issue:6

    Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Cladribine; Doxorubicin; Idarubicin; Leukemia L1210; Leukemia P388; Mice; Mitoxantrone; Survival Analysis; Time Factors; Tumor Cells, Cultured

2002
The influence of 2-chlorodeoxyadenosine (2-CdA) alone and in combination with cyclophosphamide or methotrexate on normal and leukemic hematopoiesis.
    Advances in experimental medicine and biology, 1994, Volume: 370

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cladribine; Cyclophosphamide; Hematopoiesis; Humans; Leukemia L1210; Leukemia P388; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Mice

1994
The immunosuppressive substance 2-chloro-2-deoxyadenosine modulates lipoprotein metabolism in a murine macrophage cell line (P388 cells).
    Lipids, 1994, Volume: 29, Issue:9

    Topics: Acetylation; Aminophylline; Animals; Benzamides; Cell Line; Cholesterol; Cholesterol Esters; Cladribine; Deoxycytidine Kinase; Hydroxymethylglutaryl CoA Reductases; Leukemia P388; Lipoproteins; Lipoproteins, LDL; Macrophages; Mice; NAD; Oleic Acid; Oleic Acids; Triglycerides

1994
Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Acta haematologica Polonica, 1993, Volume: 24, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cyclophosphamide; Drug Synergism; Female; Leukemia L1210; Leukemia P388; Methotrexate; Mice; Mice, Inbred DBA

1993
Additive action of gemcitabine (2',2'-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on murine leukemias L1210 and P388.
    Cancer investigation, 1999, Volume: 17, Issue:2

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Deoxycytidine; Drug Administration Schedule; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Leukemia L1210; Leukemia P388; Male; Mice

1999
Dexamethasone does not enhance antileukemic activity of cladribine in mice with leukemias L1210 and P388.
    Neoplasma, 2000, Volume: 47, Issue:3

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Dexamethasone; Disease Models, Animal; Drug Interactions; Leukemia L1210; Leukemia P388; Male; Mice; Neoplasm Transplantation; Treatment Outcome

2000